Učitavanje...
Treatment adherence in tyrosinemia type 1 patients
BACKGROUND: While therapeutic advances have significantly improved the prognosis of patients with hereditary tyrosinemia type 1 (HT1), adherence to dietary and pharmacological treatments is essential for an optimal clinical outcome. Poor treatment adherence is well documented among patients with chr...
Spremljeno u:
| Izdano u: | Orphanet J Rare Dis |
|---|---|
| Glavni autori: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BioMed Central
2021
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8173906/ https://ncbi.nlm.nih.gov/pubmed/34082789 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13023-021-01879-1 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|